Patrick O’Connor wants his group -- the Alliance to Protect Medical Innovation -- to be able to shine a light on pharmaceutical companies that he contends are taking big risks and developing innovative treatments to help patients. But he's facing a lot of skepticism. Meanwhile, cutting edge therapies are setting the health industry on fire, but their costs temper that excitement. In other pharmaceutical news: medication adherence, generics safety and more.
from Kaiser Health News https://ift.tt/2qNtapX
Subscribe to:
Post Comments (Atom)
Rose
0 comments:
Post a Comment